PDB Short entry for 1FV7 HEADER DNA 19-SEP-00 1FV7 TITLE A TWO B-Z JUNCTION CONTAINING DNA RESOLVES INTO AN ALL RIGHT HANDED TITLE 2 DOUBLE HELIX COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-D(*(5CM)P*GP*(5CM)P*GP*(0DC)P*(0DG)P*(5CM)P*GP*(5CM) COMPND 3 P*G)-3'; COMPND 4 CHAIN: A, B; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS DNA POLYMORPHISM, L ENANTIOMERY, ANTISENSE, DNA EXPDTA SOLUTION NMR NUMMDL 11 AUTHOR O.MAUFFRET,C.EL AMRI,F.SANTAMARIA,G.TEVANIAN,B.RAYNER,S.FERMANDJIAN REVDAT 6 01-FEB-17 1FV7 1 AUTHOR VERSN REVDAT 5 04-AUG-09 1FV7 1 HETATM REVDAT 4 24-FEB-09 1FV7 1 VERSN REVDAT 3 01-APR-03 1FV7 1 JRNL REVDAT 2 08-NOV-00 1FV7 1 JRNL REVDAT 1 11-OCT-00 1FV7 0 JRNL AUTH O.MAUFFRET,C.EL AMRI,F.SANTAMARIA,G.TEVANIAN,B.RAYNER, JRNL AUTH 2 S.FERMANDJIAN JRNL TITL A TWO B-Z JUNCTION CONTAINING DNA RESOLVES INTO AN ALL JRNL TITL 2 RIGHT-HANDED DOUBLE-HELIX. JRNL REF NUCLEIC ACIDS RES. V. 28 4403 2000 JRNL REFN ISSN 0305-1048 JRNL PMID 11071926 JRNL DOI 10.1093/NAR/28.22.4403 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER ET AL., 1998 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON A TOTAL OF REMARK 3 504 RESTRAINTS, 390 ARE NOE-DERIVED DISTANCE CONSTRAINTS, 104 REMARK 3 DIHEDRAL ANGLE RESTRAINTS,36 DISTANCE RESTRAINTS FROM HYDROGEN REMARK 3 BONDS. REMARK 4 REMARK 4 1FV7 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-SEP-00. REMARK 100 THE RCSB ID CODE IS RCSB011929. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 7 REMARK 210 IONIC STRENGTH : 0.1 REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 2 MM DNA; 0.1 M PHOSPHATE BUFFER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; P-COSY; TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : AMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : FELIX REMARK 210 METHOD USED : SIMULATED ANNEALING, TORSION REMARK 210 ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 11 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWER ENERGY STRUCTURES, REMARK 210 RESTRAINTS VIOLATIONS, AND THE REMARK 210 AVERAGE STRUCTURE REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 10 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 DBREF 1FV7 A 1 10 PDB 1FV7 1 10 DBREF 1FV7 B 11 20 PDB 1FV7 11 20 SEQRES 1 A 10 5CM DG 5CM DG 0DC 0DG 5CM DG 5CM DG SEQRES 1 B 10 5CM DG 5CM DG 0DC 0DG 5CM DG 5CM DG MODRES 1FV7 5CM A 1 DC MODRES 1FV7 5CM A 3 DC MODRES 1FV7 5CM A 7 DC MODRES 1FV7 5CM A 9 DC MODRES 1FV7 5CM B 11 DC MODRES 1FV7 5CM B 13 DC MODRES 1FV7 5CM B 17 DC MODRES 1FV7 5CM B 19 DC HET 5CM A 1 30 HET 5CM A 3 33 HET 0DC A 5 30 HET 0DG A 6 33 HET 5CM A 7 33 HET 5CM A 9 33 HET 5CM B 11 30 HET 5CM B 13 33 HET 0DC B 15 30 HET 0DG B 16 33 HET 5CM B 17 33 HET 5CM B 19 33 HETNAM 5CM 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE HETNAM 0DC 2'-DEOXY-L-RIBO-FURANOSYL CYTOSINE-5'-MONOPHOSPHATE HETNAM 0DG 2'-DEOXY-L-RIBO-FURANOSYL GUANINE-5'-MONOPHOSPHATE FORMUL 1 5CM 8(C10 H16 N3 O7 P) FORMUL 1 0DC 2(C9 H14 N3 O7 P) FORMUL 1 0DG 2(C10 H14 N5 O7 P) LINK O3' DG A 4 P 0DC A 5 1555 1555 1.61 LINK O3' 0DC A 5 P 0DG A 6 1555 1555 1.61 LINK O3' DG B 14 P 0DC B 15 1555 1555 1.61 LINK O3' 0DC B 15 P 0DG B 16 1555 1555 1.61 LINK O3' 5CM A 1 P DG A 2 1555 1555 1.61 LINK O3' DG A 2 P 5CM A 3 1555 1555 1.61 LINK O3' 5CM A 3 P DG A 4 1555 1555 1.61 LINK O3' 0DG A 6 P 5CM A 7 1555 1555 1.61 LINK O3' 5CM A 7 P DG A 8 1555 1555 1.61 LINK O3' DG A 8 P 5CM A 9 1555 1555 1.61 LINK O3' 5CM A 9 P DG A 10 1555 1555 1.61 LINK O3' 5CM B 11 P DG B 12 1555 1555 1.61 LINK O3' DG B 12 P 5CM B 13 1555 1555 1.61 LINK O3' 5CM B 13 P DG B 14 1555 1555 1.61 LINK O3' 0DG B 16 P 5CM B 17 1555 1555 1.61 LINK O3' 5CM B 17 P DG B 18 1555 1555 1.61 LINK O3' DG B 18 P 5CM B 19 1555 1555 1.61 LINK O3' 5CM B 19 P DG B 20 1555 1555 1.61 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000